Topic

cancer treatment

A collection of 1 issue

J&J's Treatment Boosts Survival for Lung Cancer Patients Over Tagrisso

Johnson & Johnson's new therapy significantly extends survival in non-small cell lung cancer patients, outperforming AstraZeneca's Tagrisso by over a year.